Crossmark

The <scp>FTD</scp> ‐like syndrome causing <scp>TREM</scp> 2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism

Crossref DOI link: https://doi.org/10.15252/embj.201796516

Published Online: 2017-05-30

Published Print: 2017-07-03

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Kleinberger, Gernot https://orcid.org/0000-0002-5811-8226
Brendel, Matthias

Mracsko, Eva

Wefers, Benedikt

Groeneweg, Linda

Xiang, Xianyuan

Focke, Carola

Deußing, Maximilian

Suárez‐Calvet, Marc

Mazaheri, Fargol https://orcid.org/0000-0002-6896-651X
Parhizkar, Samira

Pettkus, Nadine

Wurst, Wolfgang

Feederle, Regina

Bartenstein, Peter

Mueggler, Thomas

Arzberger, Thomas

Knuesel, Irene

Rominger, Axel

Haass, Christian https://orcid.org/0000-0002-4869-1627
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (EXC 1010 SyNergy)

Deutsche Forschungsgemeinschaft (SFB870)

H2020 European Research Council (321366‐Amyloid)

Cure Alzheimer's Fund

Seventh Framework Programme (FP7/2007–2013)
License Information

Version of Record valid from 2017-05-30
More Information

Publication History

Received: 2017-01-12

Accepted: 2017-04-27

Published: 2017-05-30